Sanofi aims to cut AI-driven drug development timelines in half with Snowflake
Source: SiliconANGLE
2026-06-03 09:13:54 ET
The pharmaceutical industry’s research and development marathon — stretching 10 to 12 years from hypothesis to approval — is set to shrink as AI-driven drug development compresses that timeline. The shift from AI experimentation to real transformation of business workflows is accelerating across industries, but few examples carry higher stakes than pharma, where a drug’s […]
The post Sanofi aims to cut AI-driven drug development timelines in half with Snowflake appeared first on SiliconANGLE .
Sanofi
NASDAQ: SNY
SNY Trading
1.75% G/L:
$45.035 Last:
1,382,086 Volume:
$45 Open:
SNY Latest News
June 03, 2026 09:13:54 am
Sanofi aims to cut AI-driven drug development timelines in half with Snowflake
SNY Stock Data
$119,804,457,217
2,430,957,423
N/A
389
N/A
Pharmaceuticals
Healthcare
FR
Paris
